Lauren Riker, Senior Vice President, Finance at Pacira BioSciences, Inc. (PCRX), sold 6,000 shares at $36.32 ($218K) on 2026-10-08, disclosed to the SEC on 2026-10-09.
Scheduled sale ($218k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2026-01-06 | $34K | — | Filing → |
| PCRX | SELL | 2025-06-05 | $292K | — | Filing → |
| PCRX | SELL | 2024-06-13 | $228K | — | Filing → |